Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elberg, G.
Right arrow Articles by Shechter, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elberg, G.
Right arrow Articles by Shechter, Y.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 46, Issue 11 1684-1690, Copyright © 1997 by American Diabetes Association


ARTICLES

Vanadate activates membranous nonreceptor protein tyrosine kinase in rat adipocytes

G Elberg, Z He, J Li, N Sekar and Y Shechter
Department of Biochemistry, Weizmann Institute of Science, Rehovot, Israel.

The insulin-like effects of vanadate are independent of the insulin receptor and insulin receptor substrate 1 (IRS-1) phosphorylation. A cytosolic protein tyrosine kinase (CytPTK), sensitive to inhibition by nanomolar concentrations of staurosporine (concentration at which 50% inhibition occurs [IC50], 1-2 nmol/l), has been implicated in some (i.e., glucose oxidation, lipogenesis) but not all (i.e., hexose uptake, inhibition of lipolysis) of the insulin-like effects of vanadate. We report here the existence of another nonreceptor protein tyrosine kinase in rat adipocytes, located exclusively in the plasma membranes (MembPTK), which we suggest is associated with hexose uptake and the antilipolytic activity of vanadate. MembPTK is a nonglycoprotein with an estimated molecular weight of 55-60 kDa. In a cell-free experiment, vanadate activates MembPTK seven- to ninefold (median effective dose, 17 +/- 2 micromol/l). Vanadate-activated MembPTK is inhibited by staurosporine (IC50, 60 +/- 5 nmol/l). In intact adipocytes, staurosporine antagonized vanadate-induced hexose uptake (IC50, 6.0 +/- 0.3 micromol/l) and significantly reversed the antilipolytic effect of vanadate (IC50, 5.0 +/- 0.4 micromol/l). After vanadate treatment, a phosphorylated P55 protein is immunoprecipitated by antibodies to both phosphotyrosine and phosphatidylinositol (PI) 3-kinase. In conclusion, rat adipocytes contain an additional vanadate-activatable nonreceptor membranous protein tyrosine kinase that may participate in the effects of vanadate not carried out by CytPTK. We also suggest that after treatment with vanadate, MembPTK is activated by autophosphorylation and interacts with PI 3-kinase. This may explain how vanadate activates PI 3-kinase without involving receptor activation and IRS-1 phosphorylation.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. Papapetropoulos, D. Fulton, M. I. Lin, J. Fontana, T. J. McCabe, S. Zoellner, G. Garcia-Cardena, Z. Zhou, J.-P. Gratton, and W. C. Sessa
Vanadate Is a Potent Activator of Endothelial Nitric-Oxide Synthase: Evidence for the Role of the Serine/Threonine Kinase Akt and the 90-kDa Heat Shock Protein
Mol. Pharmacol., February 1, 2004; 65(2): 407 - 415.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Marzban, R. Rahimian, R. W. Brownsey, and J. H. McNeill
Mechanisms by which Bis(Maltolato)Oxovanadium(IV) Normalizes Phosphoenolpyruvate Carboxykinase and Glucose-6-Phosphatase Expression in Streptozotocin-Diabetic Rats in Vivo
Endocrinology, December 1, 2002; 143(12): 4636 - 4645.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Cusi, S. Cukier, R. A. DeFronzo, M. Torres, F. M. Puchulu, and J. C. P. Redondo
Vanadyl Sulfate Improves Hepatic and Muscle Insulin Sensitivity in Type 2 Diabetes
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1410 - 1417.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
I. Goldwaser, S. Qian, E. Gershonov, M. Fridkin, and Y. Shechter
Organic Vanadium Chelators Potentiate Vanadium-Evoked Glucose Metabolism In Vitro and In Vivo: Establishing Criteria for Optimal Chelators
Mol. Pharmacol., October 1, 2000; 58(4): 738 - 746.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
I. Goldwaser, J. Li, E. Gershonov, M. Armoni, E. Karnieli, M. Fridkin, and Y. Shechter
L-Glutamic Acid gamma -Monohydroxamate. A POTENTIATOR OF VANADIUM-EVOKED GLUCOSE METABOLISM IN VITRO AND IN VIVO
J. Biol. Chem., September 10, 1999; 274(37): 26617 - 26624.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Sekar, J. Li, Z. He, D. Gefel, and Y. Shechter
Independent Signal-Transduction Pathways for Vanadate and for Insulin in the Activation of Glycogen Synthase and Glycogenesis in Rat Adipocytes
Endocrinology, March 1, 1999; 140(3): 1125 - 1131.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
B. Lu, D. Ennis, R. Lai, E. Bogdanovic, R. Nikolov, L. Salamon, C. Fantus, H. Le-Tien, and I. G. Fantus
Enhanced Sensitivity of Insulin-resistant Adipocytes to Vanadate Is Associated with Oxidative Stress and Decreased Reduction of Vanadate (+5) to Vanadyl (+4)
J. Biol. Chem., September 14, 2001; 276(38): 35589 - 35598.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1997 by the American Diabetes Association.